Palo Alto Investors was founded by William Leland Edwards in 1989. The fund usually invests in companies with market capitalization less than $3 billion.
Keep Reading →
November 8 - Hedge Funds, News
William Leland Edwards' Palo Alto Investors has about $2.22 billion worth of regulatory assets under its management.
Keep Reading →
March 2 - Hedge Funds, News
Palo Alto Investors, founded by Wall Street veteran William Leland Edwards in 1989, is one of the biggest healthcare investment shops in the United States, with over $2 billion...
Keep Reading →
December 1 - Hedge Fund Analysis, Hedge Funds, News
William Leland Edwards' Palo Alto Investors is a reputable fund with a strong focus and in-depth knowledge of healthcare stocks, a sector that accounts for more than 80% of ...
Keep Reading →
July 17 - Hedge Fund Analysis, Hedge Funds, News
James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday.
Keep Reading →
December 29 - Hedge Funds, News
Pharmaceuticals and life sciences as a sector is where most of the money from hedge funds seems to be flowing in.
Keep Reading →
October 20 - Hedge Funds, News
Jeremy Green's Redmile Group has also reduced its stake in Amicus Therapeutics, Inc.
Keep Reading →
October 9 - Hedge Funds, News
William Leland Edwards’ Palo Alto Investors disclosed today a 50% decrease in its exposure to Amicus Therapeutics, Inc. (NASDAQ:FOLD).
Keep Reading →
October 8 - Hedge Funds, News
Tim Mullen and his fund, Swift Run Capital Management, have sent a presentation to the management of VIRGINIA NATL BNK (OTCMKTS:VABK), in which they have outlined potential ...
Keep Reading →
September 26 - Hedge Funds, News
Perceptive Advisors, managed by Joseph Edelman, is bullish on Amicus Therapeutics Inc. (NASDAQ:FOLD). In a new filing with the U.S.
Keep Reading →
July 2 - Hedge Funds, News
Camber Capital Management, managed by Stephen Dubois, is bullish on Sequenom Inc. (NASDAQ:SQNM).
Keep Reading →
June 23 - Hedge Funds, News
Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD.
Keep Reading →
May 27 - Hedge Funds, News
Visium Asset Management, managed by Jacob Gottlieb, disclosed in an SEC filing that it initiated a 1.6 million position in AMAG Pharmaceuticals Inc.
Keep Reading →
March 7 - Hedge Funds, News
Samuel Isaly's Orbimed Advisors is one of the largest hedge funds focused almost entirely on the healthcare sector. In a recent intervention on CNBC, Mr.
Keep Reading →
March 6 - Hedge Funds, News
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio.
Keep Reading →
January 16 - Hedge Funds, News
Kevin Kotler's Broadfin Capital increased its exposure to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a filing with the SEC showed.
Keep Reading →
December 30 - Hedge Funds, News
William Leland Edwards' fund, Palo Alto Investors, just reported cutting down its entire position in nano-cap company Savient Pharmaceuticals Inc (OTCMKTS:SVNTQ).
Keep Reading →
November 12 - Hedge Funds, News
Anacor Pharmaceuticals, Geoffrey Parker: In a recent Form 4 filing with the SEC, M.
Keep Reading →
October 7 - Insider Trading, News
Now, according to many investors, hedge funds are assumed to be overrated, outdated investment tools of an era lost to time.
Keep Reading →
September 17 - News
As fast as we can type this, Phill Gross and Robert Atchinson's hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares of Onyx Pharmaceuticals, ...
Keep Reading →
September 9 - News
In the 21st century investor’s toolkit, there are tons of gauges investors can use to track the equity markets.
Keep Reading →
September 5 - News
Now, according to many market players, hedge funds are assumed to be bloated, outdated investment tools of a period lost to current times.
Keep Reading →
September 4 - News
To many market players, hedge funds are perceived as delayed, old financial tools of a period lost to current times.
Keep Reading →
September 3 - News
Now, according to many market players, hedge funds are viewed as bloated, outdated investment tools of a forgotten age.
Keep Reading →
September 3 - News
If you were to ask many traders, hedge funds are seen as useless, outdated investment vehicles of a period lost to current times.
Keep Reading →
August 30 - News
In the financial world, there are many indicators shareholders can use to analyze Mr. Market. A pair of the most innovative are hedge fund and insider trading activity.
Keep Reading →
August 30 - News
In the eyes of many investors, hedge funds are seen as useless, outdated investment tools of a forgotten age.
Keep Reading →
August 30 - News
In today’s marketplace, there are a multitude of methods market participants can use to monitor the equity markets.
Keep Reading →
August 29 - News
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age.
Keep Reading →
August 29 - News
If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era lost to time.
Keep Reading →
August 28 - News
To many of your fellow readers, hedge funds are assumed to be useless, old investment vehicles of a period lost to current times.
Keep Reading →
August 28 - News
In today’s marketplace, there are a multitude of methods shareholders can use to watch stocks.
Keep Reading →
August 27 - News
In the financial world, there are tons of metrics shareholders can use to analyze Mr. Market. A couple of the most innovative are hedge fund and insider trading sentiment.
Keep Reading →
August 26 - News
If you were to ask many of your fellow readers, hedge funds are assumed to be overrated, outdated financial tools of an era lost to time.
Keep Reading →
August 26 - News
STAAR Surgical Company (NASDAQ:STAA) was in 7 hedge funds' portfolio at the end of March.
Keep Reading →
June 27 - News
Cytokinetics, Inc. (NASDAQ:CYTK) was in 8 hedge funds' portfolio at the end of March.
Keep Reading →
June 24 - News
In the eyes of most stock holders, hedge funds are seen as unimportant, old investment vehicles of yesteryear.
Keep Reading →
June 17 - News
Is Cytokinetics, Inc. (NASDAQ:CYTK) the right pick for your portfolio? Prominent investors are in a bullish mood.
Keep Reading →
June 17 - News
Amicus Therapeutics, Inc. (NASDAQ:FOLD) was in 12 hedge funds' portfolio at the end of March.
Keep Reading →
June 14 - News
